EP2139485 - METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIONS, AND METHODS OF MEASURING [Right-click to bookmark this link] | Status | Patent revoked Status updated on 10.04.2019 Database last updated on 03.04.2025 | Most recent event Tooltip | 12.04.2019 | Revocation of patent | published on 15.05.2019 [2019/20] | Applicant(s) | For all designated states BioMarin Pharmaceutical Inc. 105 Digital Drive Novato, CA 94949 / US | [N/P] |
Former [2012/42] | For all designated states BioMarin Pharmaceutical Inc. 105 Digital Drive Novato, CA 94949 / US | ||
Former [2010/01] | For all designated states BioMarin Pharmaceutical Inc. 105 Digital Drive Novato, CA 94949 / US | Inventor(s) | 01 /
OPPENHEIMER, Daniel, I. 4516 Hillsborough Drive Castro Valley, CA 94546 / US | 02 /
DORENBAUM, Alejandro 120 Stanford Avenue Mill Valley, CA 94941 / US | 03 /
OKHAMAFE, Augustus 5310 Crystyl Ranch Drive Concord, CA 94521 / US | 04 /
FOEHR, Erik 1554 Buchanan Street Novato, CA 94947 / US | 05 /
CASTILLO, Sianna 400 25th Avenue, 5 San Francisco, CA 94121 / US | 06 /
KOSTEL, Paul, John 2623 Cactus Avenue Santa Rosa, CA 95405 / US | [2010/01] | Representative(s) | Weber, Martin, et al Jones Day Rechtsanwälte Attorneys-at-Law Patentanwälte Prinzregentenstrasse 11 80538 München / DE | [N/P] |
Former [2014/17] | Neuefeind, Regina, et al Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München / DE | ||
Former [2012/24] | Benz, Jürgen, et al Merck Patent GmbH Frankfurter Strasse 250 64293 Darmstadt / DE | ||
Former [2012/16] | Williams, Aylsa, et al D Young & Co LLP 120 Holborn London EC1N 2DY / GB | ||
Former [2010/01] | Dempster, Robert Charles D Young & Co 120 Holborn London EC1N 2DY / GB | Application number, filing date | 08745614.1 | 11.04.2008 | [2010/01] | WO2008US60041 | Priority number, date | US20070922821P | 11.04.2007 Original published format: US 922821 P | US20080019753 | 08.01.2008 Original published format: US 19753 | [2010/01] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2008128049 | Date: | 23.10.2008 | Language: | EN | [2008/43] | Type: | A2 Application without search report | No.: | EP2139485 | Date: | 06.01.2010 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.10.2008 takes the place of the publication of the European patent application. | [2010/01] | Type: | B1 Patent specification | No.: | EP2139485 | Date: | 17.10.2012 | Language: | EN | [2012/42] | Search report(s) | International search report - published on: | EP | 19.11.2009 | Classification | IPC: | A61K31/519, A61K45/06, A61P3/02, A61P3/00, A61P25/16 | [2010/01] | CPC: |
A61K31/519 (EP,KR,US);
A61K45/06 (EP,US);
A61K9/0019 (EP,KR,US);
A61K9/0053 (KR,US);
A61K9/0065 (EP,US);
A61K9/0095 (EP,US);
A61K9/08 (US);
A61K9/20 (KR);
A61K9/2027 (EP,US);
A61K9/2054 (EP,US);
A61K9/48 (KR);
A61K9/4808 (EP,US);
A61K9/4858 (EP,US);
A61K9/4891 (EP,US);
A61P25/00 (EP);
A61P25/06 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P3/00 (EP);
A61P3/02 (EP);
A61P43/00 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07B63/00 (EP,US);
C07D487/04 (EP,US);
G01N33/6848 (US);
A61K9/1652 (EP,US);
A61K9/2086 (EP,US);
G01N30/7233 (EP,US);
H01J49/004 (US);
Y10T436/147777 (EP,US)
(-)
| C-Set: |
A61K31/519, A61K2300/00 (EP,US)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2010/01] | Title | German: | VERFAHREN ZUR VERABREICHUNG VON TETRAHYDROBIOPTERIN, ASSOZIIERTEN ZUSAMMENSETZUNGEN UND MESSVERFAHREN | [2010/01] | English: | METHODS OF ADMINISTERING TETRAHYDROBIOPTERIN, ASSOCIATED COMPOSITIONS, AND METHODS OF MEASURING | [2010/01] | French: | PROCÉDÉS D'ADMINISTRATION DE LA TÉTRAHYDROBIOPTÉRINE, COMPOSITIONS ASSOCIÉES ET PROCÉDÉS DE MESURE | [2010/01] | Entry into regional phase | 26.10.2009 | National basic fee paid | 26.10.2009 | Designation fee(s) paid | 26.10.2009 | Examination fee paid | Examination procedure | 15.10.2009 | Amendment by applicant (claims and/or description) | 26.10.2009 | Examination requested [2010/01] | 29.07.2010 | Despatch of a communication from the examining division (Time limit: M06) | 08.12.2010 | Reply to a communication from the examining division | 11.01.2011 | Despatch of a communication from the examining division (Time limit: M02) | 10.03.2011 | Reply to a communication from the examining division | 12.08.2011 | Despatch of a communication from the examining division (Time limit: M02) | 12.10.2011 | Reply to a communication from the examining division | 20.02.2012 | Despatch of a communication from the examining division (Time limit: M02) | 29.02.2012 | Reply to a communication from the examining division | 02.05.2012 | Communication of intention to grant the patent | 18.08.2012 | Fee for grant paid | 18.08.2012 | Fee for publishing/printing paid | Divisional application(s) | EP12005352.5 / EP2545939 | EP18205446.0 / EP3461503 | EP22154751.6 / EP4029519 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 29.07.2010 | Opposition(s) | Opponent(s) | 01
17.07.2013
ADMISSIBLE Generics [UK] Limited (trading as Mylan) Albany Gate Darkes Lane Potters Bar Hertfordshire EN6 1AG / GB Opponent's representative Elend, Almut Susanne, et al, et al Venner Shipley LLP 406 Cambridge Science Park Milton Road Cambridge CB4 0WW / GB | [N/P] |
Former [2013/34] | |||
Opponent(s) | 01
17.07.2013
ADMISSIBLE Generics [UK] Limited (trading as Mylan) Albany Gate Darkes Lane Potters Bar Hertfordshire EN6 1AG / GB Opponent's representative Elend, Almut Susanne, et al, et al Venner Shipley LLP Byron House Cambridge Business Park Cowley Road Cambridge, Cambridgeshire CB4 0WZ / GB | 04.09.2013 | Invitation to proprietor to file observations on the notice of opposition | 14.03.2014 | Reply of patent proprietor to notice(s) of opposition | 09.12.2014 | Date of oral proceedings | 20.01.2015 | Despatch of interlocutory decision in opposition | 20.01.2015 | Despatch of minutes of oral proceedings | 09.11.2018 | Legal effect of revocation of patent [2019/20] | 29.03.2019 | Despatch of communication that the patent will be revoked | Appeal following opposition | 30.03.2015 | Appeal received No. T0605/15 | 01.06.2015 | Statement of grounds filed | 10.01.2019 | Result of appeal procedure: revocation of the patent | 18.03.2015 | Appeal received No. T0605/15 | 01.06.2015 | Statement of grounds filed | 10.01.2019 | Result of appeal procedure: revocation of the patent | Fees paid | Renewal fee | 26.04.2010 | Renewal fee patent year 03 | 25.04.2011 | Renewal fee patent year 04 | 28.03.2012 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US4550109 (FOLKERS KARL [US], et al) [X] 1-9 * Briding paragraph of; columns 8-9 * * column 1, paragraph 1 *; | [X]WO2004058268 (BIOCRATES LIFE SCIENCES GMBH [AT], et al) [X] 1-9 * page 39, paragraph 2 * * page 35, paragraph 1 *; | [A]US2006194808 (RICHARDSON KENNETH T [US], et al) [A] * claim 1 * | Examination | - PONZONE A ET AL, "Hyperphenylalaninemia and pterin metabolism in serum and erythrocytes.", CLINICA CHIMICA ACTA; INTERNATIONAL JOURNAL OF CLINICAL CHEMISTRY 16 JUL 1993 LNKD- PUBMED:8222274, (19930716), vol. 216, no. 1-2, ISSN 0009-8981, pages 63 - 71 | by applicant | US4550109 | US2006040946 | WO2006055511 | EP1757293 | - "Disorders oftetrahydrobiopterin and related biogenic amines", BLAU ET AL., The Metabolic and Molecular Bases of Inherited Disease, MCGRAW-HILL, (2001), pages 1275 - 1776 | - FIEGE ET AL., MOLECULAR GENETICS AND METABOLISM, (2004), vol. 81, pages 45 - 51 | - DAVIS ET AL., EUR. J. BIOCHEM., (1988), vol. 173, pages 345 - 351 | - KIRSCH ET AL., J. BIOL. CHEM., (2003), vol. 278, pages 24481 - 24490 | - Remington's Pharmaceutical Sciences, MACK PUBL. CO, (1990), page 1435 171 |